{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T09:55:59Z","timestamp":1720864559322},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T00:00:00Z","timestamp":1268265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10147-010-0051-z","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T03:07:34Z","timestamp":1268190454000},"page":"423-427","source":"Crossref","is-referenced-by-count":6,"title":["A case report of metastatic neuroendocrine carcinoma of the right adrenal gland successfully treated with chemotherapy and surgery"],"prefix":"10.1007","volume":"15","author":[{"given":"Toshiya","family":"Ochiai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosuke","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shojiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chohei","family":"Sakakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihito","family":"Kokuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhisa","family":"Sonoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eigo","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,11]]},"reference":[{"key":"51_CR1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-59655-1","volume-title":"Histological typing of endocrine tumours","author":"E Solcia","year":"2000","unstructured":"Solcia E, Kloppel G, Sobhin LH (2000) Histological typing of endocrine tumours. Springer, New York"},{"key":"51_CR2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bpg.2005.03.006","volume":"19","author":"R Arnold","year":"2005","unstructured":"Arnold R (2005) Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol 19:491\u2013505","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"51_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","volume":"449","author":"G Rindl","year":"2006","unstructured":"Rindl G, Kloppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including grading system. Virchows Arch 449:395\u2013401","journal-title":"Virchows Arch"},{"key":"51_CR4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/annonc\/mdi258","volume":"16","author":"E Bajetta","year":"2005","unstructured":"Bajetta E, Catena L, Procopio G et al (2005) Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol 16:1374\u20131380","journal-title":"Ann Oncol"},{"issue":"suppl 1","key":"51_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000051859","volume":"62","author":"P Rougier","year":"2000","unstructured":"Rougier P, Mitry E (2000) Chemotherapy in the treatment of neuroendocrine malignant tumors. Digestion 62(suppl 1):73\u201378","journal-title":"Digestion"},{"key":"51_CR6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2265.2002.01589.x","volume":"57","author":"GA Kaltsas","year":"2002","unstructured":"Kaltsas GA, Mukherjee JJ, Isidori A et al (2002) Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil. Clin Endocrinol (Oxf) 57:169\u2013183","journal-title":"Clin Endocrinol (Oxf)"},{"key":"51_CR7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/07357900601062354","volume":"24","author":"D Pectasides","year":"2006","unstructured":"Pectasides D, Pectasides M, Psyrri A et al (2006) Cisplatin-based chemotherapy for Merkel cell carcinoma of the skin. Cancer Invest 24:780\u2013785","journal-title":"Cancer Invest"},{"key":"51_CR8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/1120009X.1991.11739114","volume":"3","author":"R Ridolfi","year":"1991","unstructured":"Ridolfi R, Amaducci L, Derni S et al (1991) Chemotherapy with 5-fluorouracil and streptozotocin in carcinoid tumors of gastrointestinal origin: experiences with 13 patients. J Chemother 3:328\u2013331","journal-title":"J Chemother"},{"key":"51_CR9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000421-199802000-00008","volume":"21","author":"E Rivera","year":"1998","unstructured":"Rivera E, Ajani JA (1998) Doxorubicin, streptozotocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma. Am J Clin Oncol 21:36\u201338","journal-title":"Am J Clin Oncol"},{"key":"51_CR10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/annonc\/mdf064","volume":"13","author":"E Bajetta","year":"2002","unstructured":"Bajetta E, Ferrari L, Procopio G et al (2002) Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours. Ann Oncol 13:614\u2013621","journal-title":"Ann Oncol"},{"key":"51_CR11","first-page":"4463","volume":"25","author":"S Artale","year":"2005","unstructured":"Artale S, Giannetta L, Cerea G et al (2005) Treatment of metastatic neuroendocrine carcinomas based on WHO classification. Anticancer Res 25:4463\u20134470","journal-title":"Anticancer Res"},{"key":"51_CR12","doi-asserted-by":"crossref","unstructured":"Travis WD, Colby TV, Corrin B et al (1999) Histological typing of lung and pleural tumours. WHO international histological classification of tumours. Springer, Heidelberg","DOI":"10.1007\/978-3-642-60049-4"},{"key":"51_CR13","first-page":"1897","volume":"36","author":"S Nomura","year":"2009","unstructured":"Nomura S, Togawa A, Kaiho T et al (2009) A successful two-stage treatment with CDDP and CPT-11 for pancreatic neuroendocrine carcinoma with liver metastasis. Jpn J Cancer Chemother 36:1897\u20131900","journal-title":"Jpn J Cancer Chemother"},{"key":"51_CR14","first-page":"39","volume":"16","author":"A Sandler","year":"2002","unstructured":"Sandler A (2002) Irinotecan plus cisplatin in small-cell lung cancer. Oncology 16:39\u201343","journal-title":"Oncology"},{"key":"51_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMoa003034","volume":"346","author":"K Noda","year":"2002","unstructured":"Noda K, Nishiwaki Y, Kawahara M et al (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85\u201391","journal-title":"N Engl J Med"},{"key":"51_CR16","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2008.20.1061","volume":"27","author":"PN Lara Jr","year":"2009","unstructured":"Lara PN Jr, Natale R, Crowley J et al (2009) Phase III trial of inotecan\/cisplatin compared with etoposide\/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOGS0124. J Clin Oncol 27:2530\u20132535","journal-title":"J Clin Oncol"},{"key":"51_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3816\/CLC.2007.n.035","volume":"8","author":"L Jiang","year":"2007","unstructured":"Jiang L, Yang KH, Mi DH et al (2007) Safety of irinotecan\/cisplatin versus etoposide\/cisplatin for patients with extensive-stage small-cell lung cancer: a meta-analysis. Clin Lung Cancer 8:497\u2013501","journal-title":"Clin Lung Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-010-0051-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-010-0051-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-010-0051-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:23:27Z","timestamp":1559161407000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-010-0051-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,11]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s10147-010-0051-z","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,11]]}}}